Giulia Petroni, PhD
Post-Doctoral Associate
Apr 2019 – Jan 2022

(Co)-first Authored Publications

  1. Petroni, G., Buqué, A., Coussens L.M. and L. Galluzzi. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov, 2022. 22(6): p. 440-462.
  2. Petroni, G., Cantley, L.C., Santambrogio, L., Formenti, S.C. and L. Galluzzi. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol, 2022.  19(2): p. 114-131.
  3. Petroni, G., Buqué, A., Yamazaki, T. et al. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clin Cancer Res, 2021. 27(7): p. 1855-1863.
  4. Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G. and L. Galluzzi. Immunomodulation by targeted anticancer agents. Cancer Cell, 2021. 39(3): p. 310-345.
  5. Petroni, G., Kroemer, G. and L. Galluzzi. Immunogenic therapies drive CAR T cells towards superior efficacy. Trends Cancer, 2021. 7(3): p. 179-181.
  6. Petroni, G. and L. Galluzzi. Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents. Oncoimmunology, 2021. 10(1): p. 1889101.
  7. Petroni, G., Vitale, I. and L. Galluzzi. Caspase 2 and p53 reunited in tumor control. Trends Cell Biol, 2020. 30(12): p. 917-918.
  8. Petroni, G., Formenti, S.C., Chen-Kiang, S. and L. Galluzzi. Immunomodulation by anticancer cell cycle inhibitors. Nat Rev Immunol, 2020. 20(11): p. 669-679.
  9. Petroni, G. and L. Galluzzi. Senescence inflames the pancreatic tumor Microenvironment. Cell Rep Med, 2020. 1(2): p. 100020.
  10. Petroni, G. and L. Galluzzi. Cancer immunotherapy with CDK7 inhibitors. Trends Cancer, 2020. 6(5): p. 361-363.

(Co)-senior Authored Publications

  1. Klapp, V., Buqué, A., Bloy, N. et al. Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors. J Transl Med, 2023. 21: p. 110.
  2. Jiménez-Cortegana, C., Klapp, V., Bloy, N. et al. Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods Cell Biol, 2022. 172: p. 1-16.

Abstracts selected for Oral Presentation (First/co-first and last/co-last only)

  1. Petroni, G. Anti-tumor immune response following treatment with cell cycle inhibitors and radiation therapy. 1st Onco-Immunology Conference Day (Virtual, February 2021).
  2. Petroni, G., Gouin, K., Buquè, A. et al. Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer. 1st Paris Immuno-Oncology Conference (Paris, France, July 2021).

Abstracts Selected for Poster Presentation (First/co-first and last/co-last only)

  1. Petroni, G., Gouin, K., Buquè, A. et al. Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer. 36th Annual SITC Meeting (Washington, D.C., US, November 2021).
  2. Petroni, G., Di Liberto, M., Buquè, A. et al. Radiation therapy as a tool to sensitize HR+ breast cancer and mantle cell lymphoma to CDK4/6 inhibitors. AACR Virtual Annual Meeting 2020 (Virtual, April and June 2020).
  3. Petroni, G., Buquè, A., Di Liberto, M., et al. Radiation therapy as a tool to optimize immunomodulation by cell cycle inhibitors in HR+ breast cancer. 34th Annual SITC Meeting (Washington, D.C., US, November 2019).

Fellowships

  1. Post-Doctoral Fellowship (2019) funded by Fondazione Umberto Veronesi (Italy). 

Other achievements

  1. William Guy Forbeck Scholar Award Immunotherapies and Mechanisms of Immune Escape (2021).

Career Advancement

1.     Post-Doctoral Associate. Department of Experimental and Clinical medicine, University of Florence, Florence, Italy. Feb 2022 – Present.

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/giulia.petroni.1/bibliography/public/